Document ID: chunk:federal_register_of_legislation:F2024L01748:front:0:p1
Version: federal_register_of_legislation:F2024L01748
Segment Type: other
Provision Reference: 
Character Range: 0–3608

PB 146 of 2024
National Health (Weighted average disclosed price – April 2025 reduction day) Determination 2024
National Health Act 1953

I, DUNCAN MCINTYRE, as delegate of the Minister for Health and Aged Care, make this determination under subsection 99ADB(4) and paragraph 99ADH(1)(aa) of the National Health Act 1953.

Dated 20 December 2024

DUNCAN MCINTYRE
First Assistant Secretary
Technology Assessment and Access Division, Health Resourcing Group
Department of Health and Aged Care

Contents
1 Name...................................................................3
2 Commencement............................................................3
3 Repeal..................................................................3
4 Authority................................................................3
5 Definitions...............................................................3
Part 1 – Brands of pharmaceutical items with a weighted average disclosed price; adjusted approved ex-manufacturer price and reduction day......4
6 Weighted average disclosed price for brands of pharmaceutical items in Schedule 1 .................4
7 Adjusted approved ex-manufacturer price for brands of pharmaceutical items.....................4
8 Reduction Day.............................................................4
Part 2 – Brands of pharmaceutical items with a weighted average disclosed price.....4
9 Weighted average disclosed price for brands of pharmaceutical items in Schedule 2..................4
Schedule 1 – Brands of pharmaceutical items with a weighted average disclosed price; adjusted approved ex-manufacturer price and reduction day
Schedule 2 – Brands of pharmaceutical items with a weighted average disclosed price and no reduction day

1 Name
      1.     This instrument is the National Health (Weighted average disclosed price – April 2025 reduction day) Determination 2024.

      2.     This instrument may also be cited as PB 146 of 2024.

2 Commencement
      1.     Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Commencement information
Column 1                          Column 2                                      Column 3
Provisions                        Commencement                                  Date/Details
1.  The whole of this instrument  The day after this instrument is registered.

 (2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3 Repeal
      The National Health (Weighted average disclosed price – October 2024 reduction day) Determination 2024 (PB 67 of 2024) is repealed.

4 Authority
      This instrument is made under subsection 99ADB(4) and paragraph 99ADH(1)(aa) of the National Health Act 1953.

5 Definitions
      Note: A number of expressions used in this instrument are defined in section 99ADB of the Act, including the following:
      (a) adjusted approved ex-manufacturer price;
      (b) data collection period
      (c) unadjusted price reduction;
      (d) weighted average disclosed price.

      In this instrument:

      Act means the National Health Act 1953.

Part 1 – Brands of pharmaceutical items with a weighted average disclosed price; adjusted approved ex-manufacturer price and reduction day

6 Weighted average disclosed price for brands of pharmaceutical items in Schedule 1